Eeles R - Search Results

1

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.

Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson KL, Domchek SM, Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst FB, Verhoef S, van Dooren MF, Jager A, Ausems MG, Aalfs CM, van Asperen CJ, Vreeswijk M, Waisfisz Q, Van Roozendaal CE, Ligtenberg MJ; HEBON; EMBRACE; Easton DF, Peock S, Cook M, Oliver CT, Frost D, Curzon B, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Adlard J, Eccles D, Ong KR, Douglas F, Downing S, Brewer C, Walker L, Nevanlinna H, Aittomäki K, Couch FJ, Fredericksen Z, Lindor NM, Godwin A, Isaacs C, Caligo MA, Loman N, Jernström H, Barbany-Bustinza G, Liljegren A, Ehrencrona H, Stenmark-Askmalm M; Sw E-BRCA; Feliubadaló L, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Fortuzzi S, Johannsson OT, Chenevix-Trench G, Chen XC, Beesley J, Spurdle AB; kConFab; Sinilnikova OM, Healey S, McGuffog L, Antoniou AC, Brunet J, Radice P, Benítez J; CIMBA. Osorio A, et al. Among authors: eeles r. Br J Cancer. 2011 Apr 12;104(8):1356-61. doi: 10.1038/bjc.2011.91. Epub 2011 Mar 22. Br J Cancer. 2011. PMID: 21427728 Free PMC article.

2

The genetics of familial breast cancer and their practical implications.

Eeles RA, Stratton MR, Goldgar DE, Easton DF. Eeles RA, et al. Eur J Cancer. 1994;30A(9):1383-90. doi: 10.1016/0959-8049(94)90190-2. Eur J Cancer. 1994. PMID: 7999429 Review.

3

Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study.

Eeles RA, Dearnaley DP, Ardern-Jones A, Shearer RJ, Easton DF, Ford D, Edwards S, Dowe A. Eeles RA, et al. Br J Urol. 1997 Mar;79 Suppl 1:8-14. doi: 10.1111/j.1464-410x.1997.tb00795.x. Br J Urol. 1997. PMID: 9088267 Review. No abstract available.

4

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.

Edwards SM, Dearnaley DP, Ardern-Jones A, Hamoudi RA, Easton DF, Ford D, Shearer R, Dowe A, Eeles RA. Edwards SM, et al. Among authors: eeles ra. Br J Cancer. 1997;76(8):992-1000. doi: 10.1038/bjc.1997.498. Br J Cancer. 1997. PMID: 9376279 Free PMC article.

5

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.

Edwards SM, Dunsmuir WD, Gillett CE, Lakhani SR, Corbishley C, Young M, Kirby RS, Dearnaley DP, Dowe A, Ardern-Jones A, Kelly J, Spurr N, Barnes DM, Eeles RA. Edwards SM, et al. Among authors: eeles ra. Int J Cancer. 1998 Sep 25;78(1):1-7. doi: 10.1002/(sici)1097-0215(19980925)78:1<1::aid-ijc1>3.0.co;2-u. Int J Cancer. 1998. PMID: 9724085

6

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.

Dunsmuir WD, Edwards SM, Lakhani SR, Young M, Corbishley C, Kirby RS, Dearnaley DP, Dowe A, Ardern-Jones A, Kelly J, Eeles RA. Dunsmuir WD, et al. Among authors: eeles ra. Br J Cancer. 1998 Dec;78(11):1430-3. doi: 10.1038/bjc.1998.703. Br J Cancer. 1998. PMID: 9836474 Free PMC article.

7

The role of genetic factors in predisposition to squamous cell cancer of the head and neck.

Jefferies S, Eeles R, Goldgar D, A'Hern R, Henk JM, Gore M. Jefferies S, et al. Among authors: eeles r. Br J Cancer. 1999 Feb;79(5-6):865-7. doi: 10.1038/sj.bjc.6690138. Br J Cancer. 1999. PMID: 10070882 Free PMC article. Review.

8

Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.

Hodgson SV, Heap E, Cameron J, Ellis D, Mathew CG, Eeles RA, Solomon E, Lewis CM. Hodgson SV, et al. Among authors: eeles ra. J Med Genet. 1999 May;36(5):369-73. J Med Genet. 1999. PMID: 10353781 Free PMC article.

9

Cancer risks in BRCA2 mutation carriers.

Breast Cancer Linkage Consortium. Breast Cancer Linkage Consortium. J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6. doi: 10.1093/jnci/91.15.1310. J Natl Cancer Inst. 1999. PMID: 10433620

10

Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival.

Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R, Easton DF, Saunders GF, Dearnaley DP, Eeles RA. Edwards SM, et al. Among authors: eeles ra. Int J Cancer. 1999 Oct 22;84(5):458-65. doi: 10.1002/(sici)1097-0215(19991022)84:5<458::aid-ijc2>3.0.co;2-y. Int J Cancer. 1999. PMID: 10502720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters